These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21372741)

  • 1. Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis.
    van den Born BJ; Löwenberg EC; van der Hoeven NV; de Laat B; Meijers JC; Levi M; van Montfrans GA
    J Hypertens; 2011 May; 29(5):922-7. PubMed ID: 21372741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
    Kakar P; Lip GY
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):441-50. PubMed ID: 17489669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis.
    Derhaschnig U; Testori C; Riedmueller E; Aschauer S; Wolzt M; Jilma B
    J Hum Hypertens; 2013 Jun; 27(6):368-73. PubMed ID: 23254594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction and oxidative stress in arterial hypertension.
    Ferroni P; Basili S; Paoletti V; Davì G
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):222-33. PubMed ID: 16580590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
    J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on endothelial dysfunction and platelet activation in elderly hypertensive patients complicated with cerebral infarction].
    Li YN; Yuan H; Zhang MX
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):143-5. PubMed ID: 12536649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The vascular endothelium: physiopathology and participation in thrombogenesis].
    Chordá C; Páramo JA
    Sangre (Barc); 1995 Dec; 40(6):491-8. PubMed ID: 8850233
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombogenesis in sickle cell disease.
    Tomer A; Harker LA; Kasey S; Eckman JR
    J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome.
    Kilicarslan A; Yavuz B; Guven GS; Atalar E; Sahiner L; Beyazit Y; Kekilli M; Ozer N; Oz G; Haznedaroglu IC; Sozen T
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):310-4. PubMed ID: 18469553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Salvetti G; Salvetti A
    J Nephrol; 2000; 13(3):205-10. PubMed ID: 10928297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, haemostasis and thrombosis.
    Alessi MC; Juhan-Vague I
    Thromb Haemost; 2008 Jun; 99(6):995-1000. PubMed ID: 18521499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cigarette smoking further increases the risk of thrombosis in patients with mild hypertension].
    Fornitz GG; Hansen KF
    Ugeskr Laeger; 1997 Apr; 159(15):2230-2. PubMed ID: 9148549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S; Ignatova E; Jaillet N; Boffa MC
    Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients.
    Tomczykowska M; Bielak J; Bodys A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):15-20. PubMed ID: 15314952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in hypertension: fact or fancy?
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S41-7. PubMed ID: 9883747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
    Uchida Y
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.